These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17073580)

  • 1. Oral L-carnitine: metabolite formation and hemodialysis.
    Bain MA; Faull R; Milne RW; Evans AM
    Curr Drug Metab; 2006 Oct; 7(7):811-6. PubMed ID: 17073580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolite kinetics of oral L-carnitine in humans.
    Bain MA; Milne RW; Evans AM
    J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.
    Kalim S; Wald R; Yan AT; Goldstein MB; Kiaii M; Xu D; Berg AH; Clish C; Thadhani R; Rhee EP; Perl J
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):436-444. PubMed ID: 29444900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic model.
    Shimizu M; Yamazaki H
    J Toxicol Sci; 2017; 42(4):485-490. PubMed ID: 28717107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.
    Bain MA; Faull R; Fornasini G; Milne RW; Evans AM
    Nephrol Dial Transplant; 2006 May; 21(5):1300-4. PubMed ID: 16401621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis-related carnitine disorder and levocarnitine pharmacology.
    Evans A
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-N-oxide concentrations.
    Malinowska AM; Szwengiel A; Chmurzynska A
    Int J Food Sci Nutr; 2017 Jun; 68(4):488-495. PubMed ID: 27855528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.
    Collins HL; Drazul-Schrader D; Sulpizio AC; Koster PD; Williamson Y; Adelman SJ; Owen K; Sanli T; Bellamine A
    Atherosclerosis; 2016 Jan; 244():29-37. PubMed ID: 26584136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-carnitine on arrhythmias during hemodialysis.
    Suzuki Y; Narita M; Yamazaki N
    Jpn Heart J; 1982 May; 23(3):349-59. PubMed ID: 6178854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
    Fornasini G; Upton RN; Evans AM
    Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
    Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
    Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
    Moorthy AV; Rosenblum M; Rajaram R; Shug AL
    Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
    Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
    Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Sugiyama M; Hazama T; Nakano K; Urae K; Moriyama T; Ariyoshi T; Kurokawa Y; Kodama G; Wada Y; Yano J; Otsubo Y; Iwatani R; Kinoshita Y; Kaida Y; Nasu M; Shibata R; Tashiro K; Fukami K
    Nutrients; 2021 May; 13(6):. PubMed ID: 34073024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
    Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma concentrations of trimethylamine N-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice.
    Shimizu M; Suemizu H; Mizuno S; Kusama T; Miura T; Uehara S; Yamazaki H
    J Toxicol Sci; 2018; 43(6):387-393. PubMed ID: 29877215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.